Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients-Reference-Cited by-同舟云学术

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients

Published:2012-11-08 Issue:11 Volume:7 Page:e48959
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Rivero-Juárez Antonio,Lopez-Cortes Luis F.,Camacho Angela,Torres-Cornejo Almudena,Pineda Juan A.,Marquez-Solero Manuel,Caruz Antonio,Ruiz-Valderas Rosa,Torre-Cisneros Julian,Gutierrez-Valencia Alicia,Rivero Antonio

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV coinfected Persons. N Engl J. Med;RT Chung,2004

2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med;F Torriani,2004

3. Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4. J Antimicrob Chemother;A Rivero-Juarez,2012

4. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol;PY Bochoud,2009

5. Role of hepatitis C virus genotype 3 in liver fibrosis progression: a systematic review and meta-analysis. J Viral Hepat;A Probst,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of IL28B gene polymorphisms on PegINF-RBV-mediated HCV clearance in HIV-HCV co-infected patients: A meta-analysis;Meta Gene;2021-09

2. Treatment of Genotype 2 and Genotype 3 Hepatitis C Virus (HCV) Infection in Human Immunodeficiency Virus Positive Patients;Current HIV/AIDS Reports;2013-11-21